Wernicke’s encephalopathy and Korsakoff’s syndrome | Medibuddy
31st January 2024

Wernicke’s encephalopathy and Korsakoff’s syndrome

Background

These are both syndromes caused by thiamine deficiency as a side effect of long-term excessive alcohol consumption, which impedes the absorption and storage of consumed thiamine. Wernicke’s encephalopathy is an acute neurological disorder, whereas Korsakoff’s is a neuropsychiatric syndrome. If left untreated, Korsakoff’s syndrome can develop in a patient already diagnosed with Wernicke’s. Other conditions which can cause Korsakoff’s syndrome include AIDS and certain cancers; however, alcohol is recognised as the most common cause of the syndrome to date.

Thiamine is required for effective brain cell biochemical metabolism, particularly pyruvate metabolism – a deficiency of thiamine disrupts these necessary metabolic processes, which can cause neuronal atrophy, scar tissue formation and microscopic haemorrhages, resulting in cognitive impairment.

Presentation

The table below demonstrates the symptoms and signs seen in Wernicke’s encephalopathy and Korsakoff’s syndrome:

Wernicke’s encephalopathy Korsakoff’s syndrome
Acute confusion Anterograde and/or retrograde amnesia
Ataxic gait Confabulation
Ophthalmoplegia Visual hallucinations

Source: Adapted from: Vasan S, Kumar A. Wernicke encephalopathy – statpearls – NCBI bookshelf [Internet]. Wernicke encephalopathy. 2022 [cited 2022Dec3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470344/ and Alzheimer’s Association. Korsakoff syndrome [Internet]. Alzheimer’s Disease and Dementia. 2022 [cited 2022Dec3]. Available from: https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/korsakoff-syndrome 

Diagnosis

Both are primarily clinical diagnoses; therefore, a thorough history and examination are required to rule out other causes of the symptoms first. Imaging and lumbar puncture for CSF fluid may help identify alternate diagnoses if clinically indicated but cannot be used to diagnose Wernicke’s.

Differential diagnoses

Other causes of acute confusion hallucinations, and gait disturbance (such as delirium, primary psychiatric disorders, other substance abuse and neurological conditions) could all be differential diagnoses for either of the above presentations and must be considered during the investigation stage.

Management

Established Wernicke’s encephalopathy

Pabrinex (B vitamins including thiamine with ascorbic acid) given intravenously (IV) is required to treat Wernicke’s encephalopathy – oral thiamine is only suitable for long-term maintenance in those who are alcohol-dependent. The BNF current dosing guidelines recommends two to three pairs of Pabrinex three times a day for up to five days as treatment for established Wernicke’s encephalopathy.

Prophylaxis of Wernicke’s encephalopathy

Prophylaxis dose is 1 pair once a day intramuscularly (IM) for 5-7 days. Dose reduction can be used after this period, but oral preparations of thiamine are not suitable as an acute treatment. Literature suggests Korsakoff’s syndrome should also be treated with the same dosing of IV Pabrinex; however, the effects of this condition are often more chronic, and for some, long-term care provision is often needed, alongside standard oral thiamine maintenance. Physiotherapy and support with alcohol abstinence are also often required.

Medications to support abstinence

Those who successfully manage to abstain from alcohol may be offered additional medication to help them remain sober long-term. NICE guidance currently advises use of either acamprosate (1st line), naltrexone (alternative 1st line, not if concomitant opioid use) or, if needed, disulfiram. These treatments are summarised in the table below:

Medication Indication Cautions/contraindications
Acamprosate 1st line for reducing alcohol cravings. It can be taken for up to 6 months or longer if helpful to aid abstinence. Can cause abdominal pain, nausea, and diarrhoea. It should be discontinued if alcohol consumption continues for up to 6 weeks after starting the medication. Cannot be given to those with severe hepatic or renal impairment or those breastfeeding. Advised to avoid in pregnancy unless necessary.
Naltrexone Also 1st line – it is an opioid-receptor antagonist, so stops opioid-based analgesia from working effectively and reduces alcohol cravings. Cannot be given to those who are currently opioid dependents, advised to avoid during breastfeeding and in severe hepatic impairment. Reduced dosing may be needed in renal impairment. Advised to avoid in pregnancy unless necessary.
Disulfiram 2nd line – blocks the metabolism of alcohol after consumption. Usually started 1 day or more after the last alcoholic drink. It reacts with alcohol and causes nausea, flushing and dizziness, which is designed to discourage further alcohol intake. Cannot be used in those with active cardiovascular disease, prior stroke, hypertension, or psychosis. Should be avoided in the first trimester as acetaldehyde (the metabolite of alcohol breakdown) may be a teratogen.

Source: Adapted from: NICE. Disulfiram [Internet]. NICE. 2022 [cited 2022Dec3]. Available from: https://bnf.nice.org.uk/drugs/disulfiram/#indications-and-dose, NICE. Alcohol problem drinking: Acamprosate [Internet]. NICE. 2022 [cited 2022Dec3]. Available from: https://cks.nice.org.uk/topics/alcohol-problem-drinking/prescribing-information/acamprosate/ and NICE. Naltrexone hydrochloride [Internet]. NICE. 2022 [cited 2022Dec3]. Available from: https://bnf.nice.org.uk/drugs/naltrexone-hydrochloride/#drug-action

References 

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.